Skip to main content
Signal8
ROTHBLATT MARTINE A profile photo

Martine A. Rothblatt

CIK: 0001106578

Transaction Breakdown

Open Market Buys (P)1 (0.0%)

High conviction signal

Open Market Sales (S)2,137 (89.0%)

Position reduction

Option Exercises (M)248 (10.3%)

Derivative conversions

Awards (A)5 (0.2%)

Compensation grants

Other (G, F, J, C, D, …)11 (0.5%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

UNITED THERAPEUTICS Corp logo
UTHR

UNITED THERAPEUTICS Corp

DirectorOfficer
BETA Technologies, Inc. logo
BETA

BETA Technologies, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (2,402 total)

  • UNITED THERAPEUTICS Corp logo
    UTHR

    UNITED THERAPEUTICS Corp

    Nov 2, 2026
    Sale(S)
    Indirect
    1.3K shares at avg. $597.95$765K
  • UNITED THERAPEUTICS Corp logo
    UTHR

    UNITED THERAPEUTICS Corp

    Nov 2, 2026
    Sale(S)
    Indirect
    223 shares at avg. $593.09$132K
  • UNITED THERAPEUTICS Corp logo
    UTHR

    UNITED THERAPEUTICS Corp

    Nov 2, 2026
    Sale(S)
    Indirect
    905 shares at avg. $594.03$538K
  • UNITED THERAPEUTICS Corp logo
    UTHR

    UNITED THERAPEUTICS Corp

    Nov 2, 2026
    Exercise(M)
    Indirect
    9.5K shares at avg. $117.76$1.1M
  • UNITED THERAPEUTICS Corp logo
    UTHR

    UNITED THERAPEUTICS Corp

    Nov 2, 2026
    Sale(S)
    Indirect
    200 shares at avg. $598.84$120K
  • UNITED THERAPEUTICS Corp logo
    UTHR

    UNITED THERAPEUTICS Corp

    Nov 2, 2026
    Sale(S)
    Indirect
    2.8K shares at avg. $596.11$1.7M
  • UNITED THERAPEUTICS Corp logo
    UTHR

    UNITED THERAPEUTICS Corp

    Nov 2, 2026
    Sale(S)
    Indirect
    2.5K shares at avg. $597.02$1.5M
  • UNITED THERAPEUTICS Corp logo
    UTHR

    UNITED THERAPEUTICS Corp

    Nov 2, 2026
    Sale(S)
    Indirect
    1.6K shares at avg. $595.15$952K
  • UNITED THERAPEUTICS Corp logo
    UTHR

    UNITED THERAPEUTICS Corp

    Oct 30, 2026
    Sale(S)
    Indirect
    80 shares at avg. $606.91$49K
  • UNITED THERAPEUTICS Corp logo
    UTHR

    UNITED THERAPEUTICS Corp

    Oct 30, 2026
    Sale(S)
    Indirect
    1.2K shares at avg. $600.25$720K
  • UNITED THERAPEUTICS Corp logo
    UTHR

    UNITED THERAPEUTICS Corp

    Oct 30, 2026
    Sale(S)
    Indirect
    40 shares at avg. $608.05$24K
  • UNITED THERAPEUTICS Corp logo
    UTHR

    UNITED THERAPEUTICS Corp

    Oct 30, 2026
    Sale(S)
    Indirect
    577 shares at avg. $603.13$348K
  • UNITED THERAPEUTICS Corp logo
    UTHR

    UNITED THERAPEUTICS Corp

    Oct 30, 2026
    Sale(S)
    Indirect
    884 shares at avg. $598.94$529K
  • UNITED THERAPEUTICS Corp logo
    UTHR

    UNITED THERAPEUTICS Corp

    Oct 30, 2026
    Sale(S)
    Indirect
    1.5K shares at avg. $598.04$895K
  • UNITED THERAPEUTICS Corp logo
    UTHR

    UNITED THERAPEUTICS Corp

    Oct 30, 2026
    Sale(S)
    Indirect
    728 shares at avg. $596.01$434K
  • UNITED THERAPEUTICS Corp logo
    UTHR

    UNITED THERAPEUTICS Corp

    Oct 30, 2026
    Sale(S)
    Indirect
    183 shares at avg. $603.89$111K
  • UNITED THERAPEUTICS Corp logo
    UTHR

    UNITED THERAPEUTICS Corp

    Oct 30, 2026
    Sale(S)
    Indirect
    40 shares at avg. $605.33$24K
  • UNITED THERAPEUTICS Corp logo
    UTHR

    UNITED THERAPEUTICS Corp

    Oct 30, 2026
    Sale(S)
    Indirect
    393 shares at avg. $596.84$235K
  • UNITED THERAPEUTICS Corp logo
    UTHR

    UNITED THERAPEUTICS Corp

    Oct 30, 2026
    Sale(S)
    Indirect
    119 shares at avg. $594.92$71K
  • UNITED THERAPEUTICS Corp logo
    UTHR

    UNITED THERAPEUTICS Corp

    Oct 30, 2026
    Exercise(M)
    Indirect
    9.5K shares at avg. $117.76$1.1M
  • UNITED THERAPEUTICS Corp logo
    UTHR

    UNITED THERAPEUTICS Corp

    Oct 30, 2026
    Sale(S)
    Indirect
    1.7K shares at avg. $600.96$1.0M
  • UNITED THERAPEUTICS Corp logo
    UTHR

    UNITED THERAPEUTICS Corp

    Oct 30, 2026
    Sale(S)
    Indirect
    2K shares at avg. $601.94$1.2M
  • UNITED THERAPEUTICS Corp logo
    UTHR

    UNITED THERAPEUTICS Corp

    Oct 29, 2026
    Sale(S)
    Indirect
    1.6K shares at avg. $592.97$927K
  • UNITED THERAPEUTICS Corp logo
    UTHR

    UNITED THERAPEUTICS Corp

    Oct 29, 2026
    Sale(S)
    Indirect
    53 shares at avg. $590.43$31K
  • UNITED THERAPEUTICS Corp logo
    UTHR

    UNITED THERAPEUTICS Corp

    Oct 29, 2026
    Sale(S)
    Indirect
    1.5K shares at avg. $593.88$915K

1-25 of 2,402

…

About ROTHBLATT MARTINE A

ROTHBLATT MARTINE A (SEC CIK 0001106578) files insider reports with the SEC as Chairperson & CEO of UNITED THERAPEUTICS Corp (UTHR) and Director of BETA Technologies, Inc. (BETA).

Signal8 holds 214 ownership filings by ROTHBLATT MARTINE A (1 Form 3, 213 Form 4), filed between Mar 11, 2025 and Nov 3, 2026. Those filings report 2,402 transactions, from Mar 15, 2023 to Nov 2, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on ROTHBLATT MARTINE A's filings is in SILVER SPRING, MD.

Recent filings by ROTHBLATT MARTINE A

  • Nov 2, 2026: Open-market sales of UTHR shares (3 lines, Form 4, code S).
  • Nov 2, 2026: Option exercise of UTHR shares (Form 4, code M).
  • Nov 2, 2026: Open-market sales of UTHR shares (4 lines, Form 4, code S).
  • Oct 30, 2026: Open-market sales of UTHR shares (11 lines, Form 4, code S).
  • Oct 30, 2026: Option exercise of UTHR shares (Form 4, code M).

Other insiders filing for UNITED THERAPEUTICS Corp (UTHR)

How to read Form 4 transaction codes